Proteomics Analysis of Human Skeletal Muscle Reveals Novel Abnormalities in Obesity and Type 2 Diabetes
暂无分享,去创建一个
Benjamin P. Bowen | Lawrence J. Mandarino | C. Flynn | L. Mandarino | B. Bowen | K. Højlund | N. Lefort | C. Meyer | Zhengping Yi | Hyonson Hwang | Natalie Lefort | Charles R. Flynn | Elena A. De Filippis | Christine Roberts | Christopher C. Smoke | Christian Meyer | Kurt Højlund | Z. Yi | E. De Filippis | H. Hwang | C. Roberts
[1] Akhilesh Pandey,et al. Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS , 2008, Proceedings of the National Academy of Sciences.
[2] Tobias Straub,et al. Combined use of RNAi and quantitative proteomics to study gene function in Drosophila. , 2008, Molecular cell.
[3] R. Berria,et al. Global relationship between the proteome and transcriptome of human skeletal muscle. , 2008, Journal of proteome research.
[4] Costel C. Darie,et al. Stable Isotopic Labeling by Amino Acids in Cultured Primary Neurons , 2008, Molecular & Cellular Proteomics.
[5] Norman Pavelka,et al. Statistical Similarities between Transcriptomics and Quantitative Shotgun Proteomics Data *S , 2008, Molecular & Cellular Proteomics.
[6] C. Flynn,et al. Characterization of the Human Skeletal Muscle Proteome by One-dimensional Gel Electrophoresis and HPLC-ESI-MS/MS*S , 2008, Molecular & Cellular Proteomics.
[7] Maristela L Onozato,et al. Expression of NG,NG-Dimethylarginine Dimethylaminohydrolase and Protein Arginine N-Methyltransferase Isoforms in Diabetic Rat Kidney , 2008, Diabetes.
[8] Rebecca L. Frederick,et al. Moving Mitochondria: Establishing Distribution of an Essential Organelle , 2007, Traffic.
[9] M. Kirk,et al. Proteomic analysis of water insoluble proteins from normal and cataractous human lenses. , 2007, Molecular vision.
[10] L. Mouthon,et al. A Combined SDS‐PAGE and Proteomics Approach to Identify Target Autoantigens in Healthy Individuals and Patients with Autoimmune Diseases , 2007, Annals of the New York Academy of Sciences.
[11] X. Papademetris,et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.
[12] M. Mavroidis,et al. Muscle intermediate filaments and their links to membranes and membranous organelles. , 2007, Experimental cell research.
[13] K. Petersen,et al. Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients , 2007, Diabetes.
[14] M. Washburn,et al. Quantitative shotgun proteomics using a protease with broad specificity and normalized spectral abundance factors. , 2007, Molecular bioSystems.
[15] R. DeFronzo,et al. Paradoxical Changes in Muscle Gene Expression in Insulin-Resistant Subjects After Sustained Reduction in Plasma Free Fatty Acid Concentration , 2007, Diabetes.
[16] J. Leiper,et al. Expression of DDAH and PRMT isoforms in the diabetic rat kidney; effects of angiotensin II receptor blocker , 2007 .
[17] W. Mitch,et al. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. , 2006, Endocrinology.
[18] Michael K. Coleman,et al. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. , 2006, Journal of proteome research.
[19] P. Cerretelli,et al. The human muscle proteome in aging. , 2006, Journal of proteome research.
[20] I. Boldogh,et al. Interactions of mitochondria with the actin cytoskeleton. , 2006, Biochimica et biophysica acta.
[21] R. Berria,et al. Increased collagen content in insulin-resistant skeletal muscle. , 2006, American journal of physiology. Endocrinology and metabolism.
[22] I. Boldogh,et al. A Mammalian Actin Substitution in Yeast Actin (H372R) Causes a Suppressible Mitochondria/Vacuole Phenotype* , 2005, Journal of Biological Chemistry.
[23] E. Hoffman,et al. Proteome analysis of skeletal muscle from obese and morbidly obese women. , 2005, Diabetes.
[24] Sylvia Heeneman,et al. Proteomic analysis of differential protein expression in human atherosclerotic plaque progression , 2005, The Journal of pathology.
[25] R. DeFronzo,et al. Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle* , 2005, Journal of Biological Chemistry.
[26] B. Goodpaster,et al. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. , 2005, Diabetes.
[27] Sui Huang,et al. Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles , 2003, Bioinform..
[28] C. Reggiani,et al. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency , 2003, Nature Genetics.
[29] M. Nozaki,et al. Transcriptional Regulation of the Cytosolic Chaperonin θ Subunit Gene, Cctq, by Ets Domain Transcription Factors Elk-1, Sap-1a, and Net in the Absence of Serum Response Factor* , 2003, Journal of Biological Chemistry.
[30] K. Nair,et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. , 2003, Diabetes.
[31] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[32] A. Butte,et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[33] Aase Handberg,et al. Proteome Analysis Reveals Phosphorylation of ATP Synthase β-Subunit in Human Skeletal Muscle and Proteins with Potential Roles in Type 2 Diabetes* , 2003, The Journal of Biological Chemistry.
[34] Y. Capetanaki. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. , 2002, Trends in cardiovascular medicine.
[35] Jing He,et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.
[36] P. Tsao,et al. Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase , 2002, Circulation.
[37] K. Nair,et al. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. , 2002, Diabetes.
[38] K. Nair,et al. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. , 2002, Diabetes.
[39] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[40] L. Kunkel,et al. Myozenin: An α-actinin- and γ-filamin-binding protein of skeletal muscle Z lines , 2001 .
[41] Simon C Watkins,et al. Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Zierath,et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. , 2000, Diabetes.
[43] C. Kahn,et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.
[44] R. DeFronzo,et al. Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle. , 1999, Medicine and science in sports and exercise.
[45] H. Yanagi,et al. Structures and co-regulated expression of the genes encoding mouse cytosolic chaperonin CCT subunits. , 1999, European journal of biochemistry.
[46] P. Tsao,et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.
[47] R. Pipek,et al. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. , 1998, Diabetes.
[48] K. Nair,et al. Protein metabolism in insulin-dependent diabetes mellitus. , 1998, The Journal of nutrition.
[49] V. Shah,et al. Nitric oxide synthase inhibitors and hypertension in children and adolescents , 1997, Journal of hypertension.
[50] Nair Ks. Muscle Protein Turnover: Methodological Issues and the Effect of Aging , 1995 .
[51] K. Nair. Muscle protein turnover: methodological issues and the effect of aging. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.
[52] L. Mandarino,et al. Intracellular Defects in Glucose Metabolism in Obese Patients With NIDDM , 1992, Diabetes.
[53] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[54] R. DeFronzo. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.
[55] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[56] H. W. Lee,et al. Purification and characterization of protein methylase I (S-adenosylmethionine: protein-arginine methyltransferase; EC 2.1.1.23) from calf brain. , 1978, Methods in cell biology.
[57] Y. Habib,et al. Serum electrolytes in diabetic patients and the effect of insulin treatment. , 1959, The Journal of the Egyptian Medical Association.